Antitumor activity of recombinant antimicrobial peptide penaeidin-2 against kidney cancer cells

Ming-xiang Meng , Jian-fang Ning , Jing-you Yu , Dan-dan Chen , Xiao-lin Meng , Jin-ping Xu , Jie Zhang

Current Medical Science ›› 2014, Vol. 34 ›› Issue (4) : 529 -534.

PDF
Current Medical Science ›› 2014, Vol. 34 ›› Issue (4) : 529 -534. DOI: 10.1007/s11596-014-1310-4
Article

Antitumor activity of recombinant antimicrobial peptide penaeidin-2 against kidney cancer cells

Author information +
History +
PDF

Abstract

Penaeidin-2 (Pen-2) is an important antimicrobial peptide derived from the Pacific white shrimp, Penaeus vannamei, and possesses both antibacterial and antifungal activities. Recent studies suggest that recombinant penaeidins show similar activities to the native Pen-2 protein. Previous researches have shown that some antimicrobial peptides (AMPs) exhibit cytotoxic activity against cancer cells. To date, there have been no studies on the antitumor effects of Pen-2. This study evaluated the potential of recombinant pen-2 (rPen-2) in the selective killing of kidney cancer cell lines ACHN and A498, and its action mechanism. MTT assays found the maximal growth inhibition of HK-2, ACHN and A498 cells treated with 100 μg/mL rPen-2 at 48 h was 13.2%, 62.4%, and 70.4%, respectively. DNA-specific fluorescent dye staining showed a high percentage of apoptosis on cancer cells. Flow cytometry revealed that the apoptosis rate of HK-2, ACHN and A498 cells was 15.2%, 55.2%, and 61.5% at 48 h respectively, suggesting that rPen-2 induced higher apoptosis rate in cancer cells than in HK-2 cells. Laser confocal scanning microscopy demonstrated that the plasma membrane was the key site where rPen-2 interacted with and destroyed tumor cells. Scanning electron microscopy showed the morphologic changes of the cell membranes of kidney cancer cells treated with rPen-2. These results suggest that rPen-2 is a novel potential therapeutic agent that may be useful in treating kidney cancers.

Keywords

recombinant Penaeidin-2 / kidney cancer cell / plasma membrane / apoptosis / lysis

Cite this article

Download citation ▾
Ming-xiang Meng, Jian-fang Ning, Jing-you Yu, Dan-dan Chen, Xiao-lin Meng, Jin-ping Xu, Jie Zhang. Antitumor activity of recombinant antimicrobial peptide penaeidin-2 against kidney cancer cells. Current Medical Science, 2014, 34(4): 529-534 DOI:10.1007/s11596-014-1310-4

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

DestoumieuxD, BuletP, LoewD, et al.. Penaeidins, a new family of antimicrobial peptides isolated from the Shrimp Penaeus vannamei (Decapoda). J Biol Chem, 1997, 272(45): 28 398-28 406

[2]

CuthbertsonBJ, ShepardEF, ChapmanRW, et al.. Diversity of the penaeidin antimicrobial peptides in two shrimp species. Immunogenetics, 2002, 54(6): 442-445

[3]

KhooL, RobinetteDW, NogaEJ. Callinectin, an antibacterial peptide from blue crab, Callinectes sapidus, hemocytes. Marine Biotechnol, 1999, 1(1): 44-51

[4]

DestoumieuxD, BuletP, StrubJM, et al.. Recombinant expression and range of activity of penaeidins, antimicrobial peptides from penaeid shrimp. Eur J Biochem, 1999, 266(2): 335-346

[5]

HOSH, ChaoYC, TsaoHW, et al.. Molecular cloning and recombinant expression of Tiger Shrimp Penaeus monodon Penaeidin. Fish Pathol, 2004, 39(1): 15-23

[6]

LiL, WangJX, ZhaoXF, et al.. High level expression, purification, and characterization of the shrimp antimicrobial peptide, Ch-penaeidin, in Pichia pastoris. Protein Expr Purif, 2005, 39(2): 144-151

[7]

FuBL, XuJP, MengXL. Fusional expression of Penaeidin-2 in Escherichia coli and antibacterial activity. J Wuhan Univ (Chinese), 2006, 6(52): 739-744

[8]

GiffordJL, HunterHN, VogelHJ. Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cell Mol Life Sci, 2005, 62: 2 588-2 598

[9]

WangC, LiHB, LiS, et al.. Antitumor effects and cell selectivity of temporin-1CEa, an antimicrobial peptide from the skin secretions of the Chinese brown frog (Rana chensinensis). Biochimie, 2012, 94(2): 434-441

[10]

Thompson CoonJS, LiuZ, HoyleM, et al.. Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness. Br J Cancer, 2009, 101(2): 238-243

[11]

SiegelR, NaishadhamD, JemalA. Cancer statistics, 2012. CA Cancer J Clin, 2012, 62(1): 10-29

[12]

AsakuraT, ImaiA, Ohkubo-UraokaN, et al.. Relationship between expression of drug-resistance factors and drug sensitivity in normal human renal proximal tubular epithelial cells in comparison with renal cell carcinoma. Oncol Rep, 2005, 14(3): 601-607

[13]

AmbudkarSV, DeyS, HrycynaCA, et al.. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol, 1999, 39: 361-398

[14]

CerónJM, Contreras-MorenoJ, PuertollanoE, et al.. The antimicrobial peptide cecropin A induces caspase-independent cell death in human promyelocytic leukemia cells. Peptides, 2010, 31(8): 1494-1503

[15]

LinMC, LinSB, ChenJC, et al.. Shrimp anti-lipopolysaccharide factor peptide enhances the antitumor activity of cisplatin in vitro and inhibits HeLa cells growth in nude mice. Peptides, 2010, 31(6): 1019-1025

[16]

ChangWT, PanCY, RajanbabuV, et al.. Tilapia (Oreochromis mossambicus) antimicrobial peptide, hepcidin1-5, shows antitumor activity in cancer cells. Peptides, 2011, 32(2): 342-352

[17]

ShaiY. Mode of action of membrane active antimicrobial peptides. Biopolymers, 2012, 66(4): 236-248

[18]

SlaninováJ, MlsováV, KroupováH, et al.. Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells. Peptides, 2012, 33(1): 18-26

[19]

EliassenLT, BergeG, LeknessundA, et al.. The antimicrobial peptide, lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivo. Int J Cancer, 2006, 119(3): 493-500

[20]

CrucianiRA, BarkerJL, ZasloffM, et al.. Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation. Proc Natl Acad Sci USA, 1991, 88(9): 3792-3796

[21]

SokM, SentjurcM, ScharaM. Membrane fluidity characteristics of human lung cancer. Cancer Lett, 1999, 139(2): 215-220

[22]

KozłowskaKNJ, KwiatkowskiB, CichorekM. ESR study of plasmatic membrane of the transplantable melanoma cells in relation to their biological properties. Exp Toxicol Pathol, 1999, 51(1): 89-92

AI Summary AI Mindmap
PDF

100

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/